TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SPRY

ARS Pharmaceuticals, Inc

Healthcare · Biotechnology · —

4.10$ -1.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SPRY
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – 0.51 0.19 0.03 0.00 0.87 0.86
0.04 0.05 0.41 0.01 0.43 0.00 0.20 0.21
-0.04 -0.05 0.11 0.18 -0.40 0.00 0.67 0.65
0.45 0.65 0.41 0.70 0.46 0.21 0.19 0.13
– – 0.12 0.16 0.46 0.50 0.70 2.33
0.51 0.68 0.12 0.86 0.49 0.71 0.70 2.47
-0.55 -0.73 -0.01 -0.67 -0.89 -0.71 -0.03 -1.82
– – 0.00 0.00 0.02 – 0.00 0.03
-0.53 -0.72 -0.03 -0.70 -0.87 -0.57 0.08 -1.74
– – -0.01 -0.01 -0.02 0.00 0.00 0.00
-0.53 -0.72 -0.03 -0.70 -0.87 -0.57 0.08 -1.74
-0.51 -0.68 -0.01 -0.69 -0.86 -0.57 0.08 -1.70

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?